Karin Moelling

Active 1974–2023

Affiliations
Robert Koch InstituteUniversity of ZurichMax Planck Institute for Molecular GeneticsThis corpus build does not record the country of an author's affiliations, so none is shown here. It does not mean these institutions have no country.
52
Papers
7,874
Citations
44
h-index
51
i10-index

Self-citations are included in these numbers.

Citations per year

Citations

Citations per year for Karin Moelling1976: 1 citations1977: 3 citations1978: 1 citations1979: 1 citations1980: 1 citations1982: 2 citations1983: 17 citations1984: 22 citations1985: 26 citations1986: 25 citations1987: 20 citations1988: 32 citations1989: 61 citations1990: 49 citations1991: 28 citations1992: 17 citations1993: 27 citations1994: 15 citations1995: 17 citations1996: 38 citations1997: 25 citations1998: 42 citations1999: 28 citations2000: 126 citations2001: 141 citations2002: 137 citations2003: 141 citations2004: 129 citations2005: 108 citations2006: 98 citations2007: 82 citations2008: 87 citations2009: 50 citations2010: 64 citations2011: 67 citations2012: 47 citations2013: 32 citations2014: 49 citations2015: 26 citations2016: 21 citations2017: 21 citations2018: 32 citations2019: 91 citations2020: 120 citations2021: 81 citations2022: 82 citations2023: 54 citations2024: 74 citations2025: 30 citations2026: 1 citations1981: no citations, so this year is not shown

Citation sources

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Fields

  • Biochemistry, Genetics and Molecular Biology47.2%
  • Medicine25.7%
  • Immunology and Microbiology11.8%
  • Neuroscience4.8%
  • Environmental Science4.7%
  • Agricultural and Biological Sciences2.2%
  • Other3.6%

Topics

  • HIV Research and Treatment11.3%
  • Protein Kinase Regulation and GTPase Signaling11%
  • PI3K/AKT/mTOR signaling in cancer10.4%
  • HIV/AIDS drug development and treatment9.3%
  • Bacteriophages and microbial interactions7.5%
  • Melanoma and MAPK Pathways7.5%
  • Other42.9%

Frequent coauthors

All papers

Loading papers…

Karin Moelling | Litlas